resveratrol has been researched along with warfarin in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 14 (42.42) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Daniel, O; Frischknecht, P; Meier, MS; Schlatter, J | 1 |
| Brundin, P; Burkitt, MJ; Emgard, M; Karlsson, J | 1 |
| Chang, TK; Yeung, RK | 1 |
| Chen, HS; Guo, ZM; Wang, L | 1 |
| Koshimizu, K; Matsumoto, K; Murakami, A; Ohigashi, H | 1 |
| Liu, XJ; Ma, JW; Zhao, J; Zheng, RL | 1 |
| Borra, MT; Denu, JM; Smith, BC | 1 |
| Alcaide, C; Cano, E; Fraiz, N; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Vilar, S; Yánez, M | 1 |
| Quezada, E; Santana, L; Uriarte, E; Vilar, S; Viña, D | 1 |
| Murakami, A | 1 |
| Delogu, G; Matos, MJ; Orallo, F; Picciau, C; Quezada, E; Santana, L; Uriarte, E; Viña, D | 1 |
| Alcantara, D; Lucas, R; Morales, JC | 1 |
| Corda, M; Delogu, G; Era, B; Fadda, MB; Fais, A; Matos, MJ; Picciau, C; Podda, G; Quezada, E; Santana, L | 1 |
| Chen, K; Chen, L; Feng, Y; Jiang, H; Liu, D; Luo, C; Shen, X; Wu, J | 1 |
| Borges, F; Delogu, G; García-Morales, V; Orallo, F; Picciau, C; Podda, G; Quezada, E; Santana, L; Viña, D | 1 |
| Belluti, F; Carenini, N; Dal Bo, L; Fontana, G; Giommarelli, C; Zunino, F | 1 |
| Fang, Y; Han, G; Li, H; Wan, L; Wang, H; Wu, C; Zhang, A; Zhang, Z | 1 |
| Borges, F; Matos, MJ; Mura, F; Olea-Azar, C; Santana, L; Uriarte, E; Vazquez-Rodriguez, S | 1 |
| Chiba, T; Kimura, Y; Suzuki, S; Tatefuji, T; Umegaki, K | 1 |
| Chen, J; Ding, W; Li, S; Yu, Y | 1 |
| Agrawal, AK; Dora, CP; Garg, T; Jain, S; Kushwah, V; Thanki, K | 1 |
| Wang, Z | 1 |
| Je, HJ; Kim, ES; Lee, HG; Lee, JS | 1 |
| Ávila-Gálvez, MÁ; Espín, JC; González-Sarrías, A | 1 |
| Bencsik, T; Boda, G; Fliszár-Nyúl, E; Kunsági-Máté, S; Lemli, B; Mohos, V; Poór, M | 1 |
| Bahrami, A; Garcia-Canovas, F; Garcia-Molina, F; Hassan Khan, MT; Munoz-Munoz, J; Saboury, AA; Zolghadri, S | 1 |
| Mikstacka, R; Piekuś-Słomka, N; Ronowicz, J; Sobiak, S | 1 |
| Cadel, S; Darmon, C; Désert, A; Foulon, T; Ghélis, T; Lafont, R; Mahbouli, M; Piesse, C | 1 |
| Bazi, A; Hashemzaei, M; Hosseindadi, F; Kordi, S; Musavi, SS; Rezaee, R; Rigi, M; Shahraki, J; Shamshirgaran, F; Tabrizian, K | 1 |
| Diederich, MF; Menezes, JCJMDS | 1 |
| Hou, YC; Hsieh, YW; Huang, TY; Lin, SP; Yu, CP | 1 |
| Aguilar, LF; Borges, F; Celik, I; Delogu, G; González, C; Matos, MJ; Mella, J; Mellado, M; Uriarte, E; Viña, D | 1 |
5 review(s) available for resveratrol and warfarin
| Article | Year |
|---|---|
Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides.
Topics: Animals; Coronary Disease; Coumarins; Ecology; Flavonoids; Herbicides; Humans; Phenols; Plants; Resveratrol; Stilbenes | 1999 |
Chemoprevention with phytochemicals targeting inducible nitric oxide synthase.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Benzyl Alcohols; Catechin; Chemoprevention; Coumarins; Curcumin; Flavones; Mice; Nitric Oxide Synthase Type II; Rats; Resveratrol; Sesquiterpenes; Stilbenes | 2009 |
A comprehensive review on tyrosinase inhibitors.
Topics: Agaricales; Animals; Chalcone; Coumarins; Enzyme Inhibitors; Flavonoids; Humans; Monophenol Monooxygenase; Resveratrol | 2019 |
Hybrid
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Coumarins; Curcumin; Humans; Oleanolic Acid; Resveratrol; Stilbenes; Structure-Activity Relationship | 2019 |
Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Chalcones; Coumarins; Dimerization; DNA Topoisomerases; Humans; Molecular Structure; Neoplasms; Resveratrol; Topoisomerase Inhibitors | 2019 |
28 other study(ies) available for resveratrol and warfarin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism.
Topics: Animals; Antioxidants; Coumarins; Electron Spin Resonance Spectroscopy; Female; Free Radical Scavengers; Free Radicals; Hydroxyl Radical; L-Lactate Dehydrogenase; Mesencephalon; Pregnancy; Rats; Rats, Sprague-Dawley; Resveratrol; Spin Labels; Stilbenes; tert-Butylhydroperoxide | 2000 |
Effect of trans-resveratrol on 7-benzyloxy-4-trifluoromethylcoumarin O-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5.
Topics: Catalysis; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Inhibitors; Humans; Indicators and Reagents; Kinetics; Mixed Function Oxygenases; Recombinant Proteins; Resveratrol; Stilbenes | 2001 |
[Studies on the inhibition of polyhydroxylated aromatic compounds against HIV-1 integrase].
Topics: Coumarins; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Inhibitory Concentration 50; Naphthoquinones; Polycyclic Aromatic Hydrocarbons; Resveratrol; Stilbenes | 2002 |
Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Benzyl Alcohols; Cell Line; Coumarins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Induction; Enzyme Inhibitors; Flavones; Flavonoids; Food; Gene Expression Regulation; Genistein; I-kappa B Proteins; Interferon-gamma; Isoenzymes; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Transcription Factor RelA | 2003 |
DNA damage in healthy term neonate.
Topics: Antioxidants; Colostrum; Coumarins; DNA Damage; Fetal Blood; Flavonoids; Glutathione; Humans; Hydrogen Peroxide; Hymecromone; Infant, Newborn; Leukocytes, Mononuclear; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Phenols; Polyphenols; Quercetin; Resveratrol; Rutin; Stilbenes | 2004 |
Mechanism of human SIRT1 activation by resveratrol.
Topics: Antioxidants; Binding Sites; Binding, Competitive; Cell Cycle; Chromatography, High Pressure Liquid; Coloring Agents; Coumarins; Crystallography, X-Ray; Gene Silencing; Histidine; Histone Deacetylases; Humans; Immunoprecipitation; Kinetics; Models, Chemical; Models, Molecular; Peptides; Protein Binding; Protein Conformation; Resveratrol; Rhodamines; Sirtuin 1; Sirtuin 2; Sirtuins; Stilbenes; Substrate Specificity; Time Factors; Tumor Suppressor Protein p53 | 2005 |
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.
Topics: Animals; Aorta, Thoracic; Blood Platelets; Coumarins; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Structure; Muscle, Smooth, Vascular; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Resveratrol; Stilbenes; Thrombin; Time Factors; Vasodilator Agents; Vasomotor System | 2006 |
Assignment of the 1H and 13C NMR signals of some hydroxyphenylcoumarins.
Topics: Carbon Isotopes; Chemistry, Pharmaceutical; Coumarins; Hydrogen; Magnetic Resonance Spectroscopy; Reference Standards; Resveratrol; Stilbenes | 2007 |
A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Topics: Antioxidants; Coumarins; Drug Design; Humans; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Resveratrol; Selegiline; Stilbenes; Structure-Activity Relationship | 2009 |
A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol.
Topics: Coumarins; Glucuronides; Glycosylation; Phenylethyl Alcohol; Resveratrol; Stereoisomerism; Stilbenes | 2009 |
Tyrosinase inhibitor activity of coumarin-resveratrol hybrids.
Topics: Coumarins; Enzyme Inhibitors; Inhibitory Concentration 50; Monophenol Monooxygenase; Resveratrol; Stilbenes; Structure-Activity Relationship | 2009 |
A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.
Topics: Catechin; Coumarins; Fluorescent Dyes; NAD; Peptides; Resveratrol; Sirtuin 1; Spectrometry, Fluorescence; Stilbenes | 2009 |
Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-halo-3-phenylcoumarins.
Topics: Animals; Chromonar; Coumarins; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents; Warfarin | 2010 |
Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Line, Tumor; Chimera; Coumarins; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxides; Resveratrol; Stilbenes; Structure-Activity Relationship | 2010 |
Simultaneous determination of 14 phenolic compounds in grape canes by HPLC-DAD-UV using wavelength switching detection.
Topics: Catechin; Chromatography, High Pressure Liquid; Coumarins; Flavonoids; Phenols; Quercetin; Resveratrol; Stilbenes; Ultraviolet Rays; Vitis | 2013 |
Study of coumarin-resveratrol hybrids as potent antioxidant compounds.
Topics: Animals; Antioxidants; Cell Line; Coumarins; Macrophages; Mice; Resveratrol; Stilbenes | 2015 |
Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model.
Topics: Animals; Anticoagulants; Antioxidants; Blood Coagulation; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Combinations; Drug Synergism; Gene Expression Regulation, Enzymologic; Gnetum; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Plant Extracts; Real-Time Polymerase Chain Reaction; Resveratrol; Seeds; Stilbenes; Warfarin | 2016 |
Resveratrol and Coumarin: Novel Agricultural Antibacterial Agent against Ralstonia solanacearum In Vitro and In Vivo.
Topics: Anti-Bacterial Agents; Biofilms; Coumarins; Nicotiana; Plant Diseases; Ralstonia solanacearum; Resveratrol; Stilbenes | 2016 |
α-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Antioxidants; Area Under Curve; Biological Availability; Breast Neoplasms; Caco-2 Cells; Coumarins; Drug Delivery Systems; Emulsions; Excipients; Female; Humans; Nanoparticles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Thiazoles; Ubiquinone | 2017 |
Plant-derived antifungal compounds trigger a common transcriptional response.
Topics: Antifungal Agents; Biphenyl Compounds; Coumarins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Lignans; Oxidative Stress; Plant Extracts; Resveratrol; Schizosaccharomyces; Stilbenes; Transcription, Genetic; Up-Regulation | 2017 |
Release Properties and Cellular Uptake in Caco-2 Cells of Size-Controlled Chitosan Nanoparticles.
Topics: Biological Transport; Caco-2 Cells; Cells; Chemistry, Pharmaceutical; Chitosan; Coumarins; Drug Carriers; Humans; Nanoparticles; Particle Size; Resveratrol; Stilbenes; Thiazoles | 2017 |
Physiological Relevance of the Antiproliferative and Estrogenic Effects of Dietary Polyphenol Aglycones versus Their Phase-II Metabolites on Breast Cancer Cells: A Call of Caution.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Estrogen Antagonists; Estrogens; Female; Humans; Polyphenols; Resveratrol; Stilbenes | 2018 |
Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.
Topics: Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Flavonoids; Fluorescence; Humans; Isoflavones; Naproxen; Resveratrol; Serum Albumin; Time Factors; Warfarin | 2018 |
The effects of curcumin, mangiferin, resveratrol and other natural plant products on aminopeptidase B activity.
Topics: Aminopeptidases; Animals; Biological Products; Coumaric Acids; Coumarins; Curcumin; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Rats; Recombinant Proteins; Resveratrol; Xanthones | 2019 |
Behavioral and molecular effects of intrahippocampal infusion of auraptene, resveratrol, and curcumin on H-89-induced deficits on spatial memory acquisition and retention in Morris water maze.
Topics: Animals; Coumarins; Curcumin; Cyclic AMP Response Element-Binding Protein; Hippocampus; Infusions, Parenteral; Isoquinolines; Male; Memory; Memory Disorders; Neuroprotective Agents; Rats, Wistar; Resveratrol; Sulfonamides | 2019 |
Resveratrol stereoselectively affected (±)warfarin pharmacokinetics and enhanced the anticoagulation effect.
Topics: Animals; Anticoagulants; Blood Coagulation; Cell Line; Cell Survival; Dogs; Drug Interactions; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Warfarin | 2020 |
Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin
Topics: Catalytic Domain; Coumarins; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Resveratrol; Styrenes | 2022 |